Case Studies
Case study: an ambispective study featuring retrospective chart review and prospective cross-sectional surveys
February 20, 2024
Menu
Menu
A large global pharma company was required to run a complex global safety study by the regulatory authorities. This was
Baseline Plus provided the ideal platform to enable a specialised European Pharma company to run a post approval safety study
Cisiv’s electronic data capture (EDC) platform, Baseline Plus, is built specifically to meet the complex needs of post-approval research. Its
A leading global pharmaceutical company was looking for a fit-for-purpose technology and methodology to evaluate the effectiveness of an anti-psychotic
This joint blog between Cisiv and Boyds discusses the strategic reasons for collecting real world data (RWD) alongside expanded access
Patient registries are organised systems that use observational methods to collect uniform data to evaluate specified outcomes for a population
Recorded: 5 October 2023 An expanded access programme is a legislative framework, used by both the European Medicines Agency (EMA) and the Food and
For years, the prospect of ‘virtual’ and decentralised research was discussed with hope as a potential disruptor to enable greater
Get in touch today to speak to one of our expert team and find out how we can help you with your study.
© Copyright Cisiv 2024 | Registered Company Number: 3110147
© Copyright Cisiv
To find out more about the Cisiv technology and how we can help you with your study.